Antiviral Treatment of Chikungunya Virus Infection

Author(s): Xavier de Lamballerie, Laetitia Ninove, Remi N. Charrel

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders

Volume 9 , Issue 2 , 2009

Become EABM
Become Reviewer
Call for Editor


Chikungunya virus is a typical emerging virus which has been responsible for several million cases of human infections since 2004. No antiviral treatment is currently available. The antimalarial chloroquine has been used in the past but recent studies suggest that it is not or poorly active in vivo. A number of tracks are currently under investigation (inhibition of viral enzymes, of virus entry or maturation, enhancement of immunological response) and new animal models have been made available, including a mouse model and a non-human primate model. We review here the main perspectives of chikungunya antiviral treatment.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Published on: 01 March, 2012
Page: [101 - 104]
Pages: 4
DOI: 10.2174/187152609787847712
Price: $65

Article Metrics

PDF: 9